{
    "clinical_study": {
        "@rank": "126049", 
        "arm_group": {
            "arm_group_label": "AMD with macular drusen", 
            "description": "Patients diagnosed with dry AMD with macular drusen"
        }, 
        "brief_summary": {
            "textblock": "The objective of this study is to determine the repeatability and reproducibility of the\n      Cirrus HD-OCT measurements of drusen area and volume."
        }, 
        "brief_title": "Repeatability and Reproducibility of Cirrus HD-OCT Macular Retinal Pigment Epithelium Elevation", 
        "completion_date": {
            "#text": "June 2011", 
            "@type": "Actual"
        }, 
        "condition": "Dry AMD With Macular Drusen", 
        "detailed_description": {
            "textblock": "This is a prospective, single site study. Ocular history and examination will be conducted\n      on consented subjects to determine further participation in the study. The study will be\n      divided into two phases.  In Phase 1, the inter-device variability of Cirrus HD-OCT\n      measurements of drusen area and volume will be determined.  In Phase 2, the inter-operator\n      variability of Cirrus HD-OCT measurements of drusen area and volume will be determined.  In\n      each of these phases, the Macular Cube 200 x 200 scan and the Macular Cube 512 x 128 scan\n      will be evaluated."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Males or females 50 years of age or older diagnosed to have dry AMD with macular\n             drusen.\n\n          2. Drusen should not be combined with other lesions such as geographic atrophy (GA) or\n             choroidal neovascularization.\n\n          3. Able and willing to make the required study visits.\n\n          4. Able and willing to give consent and follow study instructions.\n\n        Exclusion Criteria:\n\n          1. History of retinal surgery, laser photocoagulation, and/or radiation therapy to the\n             eye.\n\n          2. Evidence of other retinal diseases of the eye, including wet AMD, diabetic\n             retinopathy, diabetic macular edema, or significant vitreomacular traction.\n\n          3. Thick media opacity or inability to fixate that precludes obtaining acceptable scans.\n\n          4. Concomitant use of hydrochloroquine or chloroquine.\n\n          5. Unable to make the required study visits.\n\n          6. Unable to give consent or follow study instructions."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "50 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Primary care clinic"
            }
        }, 
        "enrollment": {
            "#text": "54", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "June 24, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01890174", 
            "org_study_id": "HD-OCT-DR-2010-2"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "June 27, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Mountain View", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "94040"
                }, 
                "name": "Northern California Retina Vitreous Associates"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Repeatability and Reproducibility of Cirrus HD-OCT Macular Retinal Pigment Epithelium Elevation", 
        "other_outcome": [
            {
                "measure": "Coefficient of variation for area (mm^2) of RPE elevation measurements in the central 5 mm circle.", 
                "safety_issue": "No", 
                "time_frame": "Single visit observation"
            }, 
            {
                "measure": "Coefficient of variation for volume (mm^3) of RPE elevation measurements in the central 5 mm circle.", 
                "safety_issue": "No", 
                "time_frame": "Single visit observation"
            }
        ], 
        "overall_official": {
            "affiliation": "Northern California Retina Vitreous Associates Medical Group, Inc.", 
            "last_name": "Mark Wieland, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "United States: RCRC Independent Review Board"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Coefficient of variation for area (mm^2) of RPE elevation measurements in the central 3 mm circle.", 
            "safety_issue": "No", 
            "time_frame": "Single visit observation"
        }, 
        "reference": {
            "PMID": "19171212", 
            "citation": "Schmitz-Valckenberg S, Fleckenstein M, Scholl HP, Holz FG. Fundus Autofluorescence and Progression of Age-related Macular Degeneration. Surv Ophthalmol. 2009 Jan-Feb;54(1):96-117."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01890174"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Coefficient of variation for volume (mm^3) of RPE elevation measurements in the central 3 mm circle.", 
            "safety_issue": "No", 
            "time_frame": "Single visit observation"
        }, 
        "source": "Carl Zeiss Meditec, Inc.", 
        "sponsors": {
            "collaborator": {
                "agency": "DataMed Devices Inc.", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Carl Zeiss Meditec, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2011", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "June 2013"
    }
}